Why the study?
The pathogenesis of hypertensive heart disease remains unclear, but may involve autoimmunity.
Are autoantibodies against cardiovascular receptors associated with the presence and severity of hypertensive heart disease?
Are autoantibodies against cardiovascular receptors associated with the presence and severity of hypertensive heart disease?
Answers are grounded in this paper and cite their sources.
Multiple autoantibodies against cardiovascular receptors are significantly elevated in hypertensive heart disease and correlate with worse left ventricular remodeling and function.
Objectives: The pathogenesis of hypertensive heart disease (HHD) remains unclear, which might include autoimmunity. The aim of the present study was to determine whether a relationship exists between the presence of autoantibodies against β₁, β₂, α₁ adrenoreceptors, M₂-muscarinic receptors, angiotensin II type₁ receptors and HHD. Methods: In the present study, 44 patients diagnosed with HHD, 36 patients with hypertension, and 40 controls were also enrolled. The measurement of these 5 autoantibodies was performed by enzyme-linked immunosorbent assay. Results: The frequencies of autoantibodies against β₁, β₂, α₁ adrenoreceptors, autoantibodies against M₂-muscarinic receptors and autoantibodies against angiotensin II type₁ receptors were significantly higher in patients with HHD, when compared to patients with hypertension and normal controls (all p < 0.001). In addition, the titers of these 5 autoantibodies significantly increased in patients with HHD. Patients who were positive for all 5 autoantibodies had larger left ventricular end-diastolic diameter (60.5 ± 4.9 vs. 57.8 ± 5.0 vs. 52.5 ± 5.3 mm) and worse left ventricular ejection fraction (45.0 ± 11.0 vs. 56.6 ± 10.4 vs. 57.8 ± 5.3%), when compared to patients not positive for all the 5 autoantibodies and patients negative for all the 5 autoantibodies (χ² = 9.524, p = 0.009 and χ² = 7.689, p = 0.021). Furthermore, a significant positive correlation was observed between each 2 autoantibodies of these 5 autoantibodies (all p < 0.001). Conclusion: Multiple autoantibodies of cardiovascular receptors may be involved in the pathogenesis and may be predictive factors of HHD.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: